| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1025022037 |
| P356 | DOI | 10.1186/S40779-015-0068-8 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/s40779-015-0068-8 |
| P932 | PMC publication ID | 4687099 |
| P698 | PubMed publication ID | 26697189 |
| P5875 | ResearchGate publication ID | 287796598 |
| P2093 | author name string | Guillermo Giménez-Gallego | |
| Pedro Cuevas | |||
| Javier Angulo | |||
| Carlos Azanza | |||
| Luis Antonio Outeiriño | |||
| P2860 | cites work | Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitors | Q24298832 |
| Dry eye: an inflammatory ocular disease | Q26852044 | ||
| Prevalence of dry eye syndrome among US women | Q28196875 | ||
| Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome | Q33592784 | ||
| Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids | Q33979505 | ||
| The core mechanism of dry eye disease is inflammation | Q34510429 | ||
| Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity? | Q34952967 | ||
| Long-term effectiveness of dobesilate in the treatment of papulopustular rosacea | Q35519637 | ||
| Upregulation of NLRP3 Inflammasome in the Tears and Ocular Surface of Dry Eye Patients | Q35592392 | ||
| Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients | Q35717311 | ||
| Impact of dry eye syndrome on vision-related quality of life | Q35741609 | ||
| Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease | Q36776787 | ||
| b-FGF induces corneal blood and lymphatic vessel growth in a spatially distinct pattern | Q36892952 | ||
| Dry eye disease: an immune-mediated ocular surface disorder | Q36916372 | ||
| Etiology, prevalence, and treatment of dry eye disease | Q37288773 | ||
| Placebo controlled trial of fusidic acid gel and oxytetracycline for recurrent blepharitis and rosacea | Q37309955 | ||
| Inflammatory cells and chemokines sustain FGF2-induced angiogenesis. | Q37525703 | ||
| Diacetyloxyl derivatization of the fibroblast growth factor inhibitor dobesilate enhances its anti-inflammatory, anti-angiogenic and anti-tumoral activities | Q38914613 | ||
| Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group | Q40765221 | ||
| Topical treatment of contact dermatitis by pine processionary caterpillar | Q41880890 | ||
| Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor | Q42447438 | ||
| Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. | Q44473550 | ||
| The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study | Q44600963 | ||
| Assessment of the anti-inflammatory action of calcium dobesilate. Effect on macrophages attaching to subcutaneously implanted coverslips in guinea pigs. | Q44787657 | ||
| Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye. | Q45950875 | ||
| Inflammation in dry eye. | Q46372528 | ||
| Systemic immunomodulatory therapy in severe dry eye secondary to inflammation. | Q51750765 | ||
| Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial proliferation, arterial relaxation, vascular permeability and angiogenesis by dobesilate. | Q54579207 | ||
| A pro-inflammatory signature mediates FGF2-induced angiogenesis | Q57006104 | ||
| Cell release of bioactive fibroblast growth factor 2 by exon 6-encoded sequence of vascular endothelial growth factor | Q73717921 | ||
| The pathology of dry eye: the interaction between the ocular surface and lacrimal glands | Q77575256 | ||
| The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) | Q80347907 | ||
| Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007) | Q80347919 | ||
| The economic burden of dry eye: a conceptual framework and preliminary assessment | Q80902614 | ||
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 35 | |
| P577 | publication date | 2015-12-21 | |
| P1433 | published in | Military Medical Research | Q27726127 |
| P1476 | title | Improvement in the signs and symptoms of dry eye disease with dobesilate eye drops | |
| P478 | volume | 2 |
Search more.